About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- SoftBank plans to lend up to $20 billion to employees to invest in new fund: WSJ
- The often-hated open floor plan gets a new savior: The office pod
- Why YouTube's Susan Wojcicki limits her own kids' screen time
- Massive Arctic wildfires emitted more CO2 in June than Sweden does in an entire year
- The price of a cup of coffee may be the answer to fixing Social Security
NBR on TwitterMy Tweets
Subscribe to RSS
John Harwood joins us to break down the first night of the Democratic Presidential Debate from Detroit where healthcare was in the spotlight.
Representatives from Apple, Google, Amazon and Microsoft joined up in Washington D.C. on Tuesday, alongside some of the largest health insurers and hospitals, to announce plans to provide consumers with easier access to their medical information.
Drug maker companies Merck and Eli Lilly posted better than expected results in its quarterly earnings reports. Meg Tirrell takes a closer look at both of these big pharmaceutical firms.
President Donald Trump is working on a proposal that would allow the United States to import drugs from Canada, Health and Human Services Secretary Alex Azar told CNBC.
Pfizer will be merging with its off patent business with Mylan creating a new company that controls a number of blockbuster medicines. Meg Tirrell has more for us on this mega deal.
Sen. Kamala Harris released a health care plan on Monday that will transition every American into her version of a “Medicare for All” system within 10 years.
Juul co-founder James Monsees defended the e-cigarette start-up in a congressional hearing Thursday, saying the company “never wanted” minors to use its products, while admitting the company made “missteps.”
Senate Finance Committee Chairman Chuck Grassley said Thursday that he wants to include an abandoned White House proposal that would have eliminated rebates from government drug plans in the final version of a bipartisan drug pricing bill.
If you’re among the growing contingent of Americans who plan to continue to work after age 65, be sure to review your Medicare options before you do eventually decide to finally say farewell to your coworkers.
Just over a year after buying online pharmacy PillPack for $753 million, Amazon is engaged in a bitter battle with an incumbent player in the pharmacy industry, which sources tell CNBC is working behind the scenes to prevent the company from accessing important patient data.
Philip Morris International beat second-quarter earnings and revenue estimates and hiked its full-year forecast Thursday as its new tobacco products gained momentum.
The House is scheduled to vote Wednesday on a bill that would scrap Obamacare’s so-called “Cadillac tax,” an inactive provision of the health law meant to help control health-care spending.
Johnson & Johnson topped analysts’ expectations and increased its guidance. But, the company is under increased scrutiny and pressure. Meg Tirrell explains why.
Johnson & Johnson vowed to defend itself against lawsuits alleging the company fueled the opioid crisis and that its namesake talc-based baby powder caused ovarian cancer and mesothelioma.
The FDA reports teens’ use with e-cigarettes have dramatically increased. Carl Quintanilla reports on this issue and speaks with Juul’s executives at their labs about the popularity of the product among teens.